3 New Strong Buy Ratings from Top-Rated Analysts: 07/28/2026
Check it out. Here’s a no-paywall peek at the latest from our Strong Buy Stocks from Top Wall Street Analysts screener:
- Bioventus (BVS): The #1-rated stock in our 4600+ stock database
- HF Sinclair (DINO): Tops an A-rated industry with over 20% upside potential
- Marathon Petroleum (MPC): 7 Strong Buys fuel this refining giant
P.S. Get more alerts like this daily … Try WallStreetZen Premium.
A note from our sponsors...
Hoping to Retire Soon?
There's a 73-minute "trading window" that is commonly exploited by retirees and those hoping to retire sooner. It works best if you can make this trade at a very specific time of day.
Click here to know when you should make this morning trade.
1. HF Sinclair (NYSE: DINO)
As refining margins stabilize and renewable diesel gains traction, this diversified energy company is well-positioned to benefit from both traditional and transitioning energy markets.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $88.30 — get current quote
Max 1-year forecast: $109.00
Why we're watching:
- DINO has strong, bullish coverage among the analysts we track, with 6 Strong Buy, 1 Buy, and 8 Hold recommendations. See all recommendations here
- For example, Goldman Sachs researcher Neil Mehta (a top 5% rated analyst) recently maintained his Strong Buy rating with a price target suggesting the stock could see over 20% upside in the coming year.
- Industry ranking context: DINO is currently the #1 highest-rated stock in the Oil & Gas Refining & Marketing industry, which has an Industry Rating of A.
- Zen Ratings highlights: DINO earns an overall A rating, which is equal to a Strong Buy recommendation. Stocks in this topmost tier have historically delivered nearly 30% annual returns, soundly beating the S&P.
- Component Grades: DINO excels with As for Artificial Intelligence, Momentum, Growth, and Value, a rare four-A combination reflecting accelerating business trends, a powerful price uptrend, and a valuation that hasn't caught up to them, while maintaining strong Bs for Financials and Sentiment, positioning it well for continued appreciation. See all 7 Component Grades here
2. Marathon Petroleum (NYSE: MPC)
With strong refining assets and improving operational efficiency, this energy company is capitalizing on robust demand and favorable crack spreads in the energy sector.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $309.24 — get current quote
Max 1-year forecast: $376.00
Why we're watching:
- MPC has solid, bullish coverage among the analysts we track, with 7 Strong Buy, 3 Buy, and 4 Hold recommendations. See all recommendations here
- For example, Goldman Sachs researcher Neil Mehta (a top 5% rated analyst) recently maintained his Strong Buy rating with a price target suggesting over 20% upside potential in the coming year.
- Industry ranking context: MPC is currently the #4 highest-rated stock in the Oil & Gas Refining & Marketing industry, which has an Industry Rating of A.
- Zen Ratings highlights: MPC earns an overall A rating, which amounts to a Strong Buy recommendation. This tier represents the elite top 5% of stocks tracked based on a rigorous 115-factor fundamental review.
- Component Grades: MPC excels with As for Growth, Momentum, and Sentiment, reflecting strong market momentum and positive analyst reception, while maintaining a solid B for Value. See all 7 Component Grades here
3. Bioventus (NASDAQ: BVS)
Ranked #1 in the entire Zen Ratings system, this medical device company is positioned to capitalize on growing demand in orthopedic and pain relief markets.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $11.80 — get current quote
Max 1-year forecast: $16.00
Why we're watching:
- BVS has limited, but overall bullish, coverage among the analysts we track, with 1 Strong Buy and 2 Buy recommendations. See all recommendations here
- For example, Canaccord Genuity researcher Caitlin Cronin (a top 16% rated analyst) recently maintained her Strong Buy rating with a price target that suggests the stock could see nearly 30% upside in the coming year.
- On top of that, BVS is our most recent Stock of the Week selection. In his commentary, Zen Investor Editor-in-Chief Steve Reitmeister highlighted the stock’s elite ranking in our quant system (#1 out of over 4600 stocks based on fundamentals!) and how it is benefiting from multiple tailwinds. See his full writeup here.
- Industry ranking context: BVS is currently the #1 highest-rated stock in the Medical Device industry, which has an Industry Rating of C.
- Zen Ratings highlights: BVS earns an overall A rating, which amounts to a Strong Buy recommendation. Stocks with this rating represent the elite top 5% of all stocks tracked based on a rigorous 115-factor fundamental review.
- Component Grades: BVS excels with As for Growth and Sentiment, reflecting strong expansion potential and positive market reception, while maintaining solid Bs for Financials, Safety, and Value. See all 7 Component Grades here
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.
Keep Reading
See All News
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.